Your browser doesn't support javascript.
loading
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86.
Yang, Sijie; Yu, Yuanling; Jian, Fanchong; Song, Weiliang; Yisimayi, Ayijiang; Chen, Xiaosu; Xu, Yanli; Wang, Peng; Wang, Jing; Yu, Lingling; Niu, Xiao; Wang, Jing; Xiao, Tianhe; An, Ran; Wang, Yao; Gu, Qingqing; Shao, Fei; Jin, Ronghua; Shen, Zhongyang; Wang, Youchun; Cao, Yunlong.
Affiliation
  • Yang S; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; Peking-Tsinghua Centre for Life Sciences, Tsinghua University, Beijing, China.
  • Yu Y; Changping Laboratory, Beijing, China.
  • Jian F; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Song W; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Yisimayi A; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Chen X; Institute for Immunology, College of Life Sciences, Nankai University, Tianjin, China.
  • Xu Y; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wang P; Changping Laboratory, Beijing, China.
  • Wang J; Changping Laboratory, Beijing, China.
  • Yu L; Changping Laboratory, Beijing, China.
  • Niu X; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China.
  • Wang J; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Xiao T; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
  • An R; Changping Laboratory, Beijing, China.
  • Wang Y; Changping Laboratory, Beijing, China.
  • Gu Q; Changping Laboratory, Beijing, China.
  • Shao F; Changping Laboratory, Beijing, China.
  • Jin R; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Shen Z; Organ Transplant Centre, National Health Commission Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, China.
  • Wang Y; Changping Laboratory, Beijing, China; Institute of Medical Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China.
  • Cao Y; Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China. Electronic address: yunlongcao@pku.edu.cn.
Lancet Infect Dis ; 23(11): e457-e459, 2023 11.
Article in En | MEDLINE | ID: mdl-37738994
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: China Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: China Country of publication: Estados Unidos